Richard J. Barohn - Concepedia

Author

Richard J. Barohn

University of Kansas Medical Center ORCID

Also Known As

Barohn, Richard J., Campbell, Craig, Jackson, Carlayne, Peter Kang, R J Barohn, R. Barohn, R. J Barohn, R. J. Barohn, R.J Barohn, R.J. Barohn

270

Publications

14.6K

Citations

H-Index

Concepts

All Affiliations

University of Kansas Medical Center The University of Texas Health Science Center at San Antonio The University of Texas Southwestern Medical Center University of Miami University of North Carolina at Chapel Hill

About

Richard J. Barohn is an author at University of Kansas Medical Center specializing in medicine, autoimmune disease, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	3.9K
2	Health Sciences	5	5	630
3	Social Sciences	2	2	141
4	Public Health	1	1	17
5	Allergy	1	1	26

Richard J. Barohn

Publications

Citations

H-Index

Page 1

	Year	Citations
Mutations in Kir2.1 Cause the Developmental and Episodic Electrical Phenotypes of Andersen's Syndrome Nikki Plaster, Rabi Tawil, Martin Tristani‐Firouzi, Cell Episodic Electrical PhenotypesDevelopmental BiologyGenetic DisorderGeneticsPhysiology	2001	991
Randomized Trial of Thymectomy in Myasthenia Gravis Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, New England Journal of Medicine	2016	873
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study James F. Howard, Kimiaki Utsugisawa, Michael Benatar, The Lancet Neurology Multicentre StudyPharmacologyMedicineMyasthenia GravisNeuromuscular Blockade	2017	745
Myasthenia gravis: recommendations for clinical research standards Alfred Jaretzki, Richard J. Barohn, Raina M. Ernstoff, The Annals of Thoracic Surgery	2000	638
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial James F. Howard, Vera Bril, Tuan Vu, The Lancet Neurology MedicineGeneralised Myasthenia Gravis	2021	587
Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) [RETIRED] Gary Gronseth, Richard J. Barohn Neurology	2000	580
Myasthenia gravis activities of daily living profile Gil I. Wolfe, Laura Herbelin, Sharon Nations, Neurology Non-pharmacological InterventionKinesiologyBody CompositionPsychiatryQuantitative Mg Score	1999	510
Predictors of Clinical Improvement in Rituximab‐Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis Rohit Aggarwal, Andriy I. Bandos, Ann M. Reed, Arthritis & Rheumatology	2013	274
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, Muscle & Nerve	2019	239
A randomized, double‐blind, placebo‐controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis James F. Howard, Richard J. Barohn, Gary Cutter, Muscle & Nerve	2013	223

Page 1